Taken together, our findings strongly suggest that the ERK1/2 signaling pathway could be involved in CCL17 and CCL22 effects in obesity-related endothelial dysfunction. The gene discussed is CCL17; the disease is obesity due to melanocortin 4 receptor deficiency.